Page last updated: 2024-08-24

gemcitabine and CCMMT

gemcitabine has been researched along with CCMMT in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antoniou, G; Bertulli, R; Blay, JY; Brahmi, M; Casali, PG; Collini, P; Dei Tos, AP; Dufresne, A; FucĂ , G; Fumagalli, E; Gronchi, A; Grosso, F; Hindi, N; Jones, RL; Le Cesne, A; Mir, O; Provenzano, S; Sanfilippo, R; Sbaraglia, M; Stacchiotti, S1
Carbone, A; Di Cristofano, C; Evangelista, S; Palleschi, G; Pastore, AL; Petrozza, V; Porta, N; Rossi, L; Silvestri, L; Tomao, S1

Other Studies

2 other study(ies) available for gemcitabine and CCMMT

ArticleYear
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 09-01, Volume: 25, Issue:17

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Everolimus; Female; Gemcitabine; Humans; Indazoles; International Agencies; Male; Middle Aged; Perivascular Epithelioid Cell Neoplasms; Prognosis; Pyrimidines; Retrospective Studies; Sirolimus; Sorafenib; Sulfonamides; Survival Rate; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor Receptor-1

2019
Bone metastases from bladder perivascular epithelioid cell tumor - an unusual localization of a rare tumor: a case report.
    Journal of medical case reports, 2014, Jun-25, Volume: 8

    Topics: Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Deoxycytidine; Gemcitabine; Humans; Ilium; Male; Perivascular Epithelioid Cell Neoplasms; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

2014